Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Lupus can cause hair loss and nail changes, with treatments available for both.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document explains various skin conditions and their treatments.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.